跳至主要内容
临床试验/CTRI/2023/10/058952
CTRI/2023/10/058952尚未招募2 期

Pharmacognostic andExperimnental Evaluation of Panchavalkala for Lekhana Karma W.s.r toAnti-Hyperlipedimic Activity - NI

A0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
A

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients who are confirmed to have increased levels of Cholesterol, Triglycerides and LDL with the help of a Lipid Profile Test.

排除标准

  • 1. Patients who are K/C/O DM and HTN not under control
  • 2. Immunocompromised patients
  • 3. Patients with severe systemic illness.

研究者

发起方
A

相似试验